Literature DB >> 15963208

Type 2 diabetes mellitus: a cardiovascular perspective.

G I Varughese1, J Tomson, G Y H Lip.   

Abstract

Diabetes mellitus is a disease, which is at the epitome of cardiovascular risk factors causing considerable morbidity and mortality. In addition to microvascular complications, there is two- to six-fold increased risk of macrovascular diseases, such as coronary artery disease, peripheral artery disease and stroke. While the mortality from coronary artery disease in patients without diabetes has declined over the past 20 years, the mortality in men with type 2 diabetes mellitus has not changed. Furthermore, the prevalence of diabetes in the UK has increased by 30% since 1991 and the same among the world population in 2010 is expected to be twice in 1990. This dramatic increase has serious implications from a cardiovascular perspective and thus the aggressive management of blood pressure, dyslipidaemia and blood glucose in diabetes is of vital importance. The aim of this review is to evaluate the current evidence and to discuss the implications of type 2 diabetes and its relevance to clinical practice in cardiology. We address this broad subject in discussing (i) the pathophysiology of cardiovascular disease in the setting of type 2 diabetes and (ii) the prevalence of cardiovascular risk, complications and prognostic implications in type 2 diabetes, with a discussion of current therapeutic interventions for the prevention or delay of these consequences where relevant.

Entities:  

Mesh:

Year:  2005        PMID: 15963208     DOI: 10.1111/j.1368-5031.2005.00571.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  7 in total

1.  Optimizing diabetes care: perspectives from a practical view point.

Authors:  George I Varughese; Divakar Jammalamadaka; Abd A Tahrani
Journal:  J R Soc Med       Date:  2007-02       Impact factor: 5.344

2.  Decreasing the diabetic complication by vanadyl(VO)2+/vitamin B 6 complex in alloxan-induced diabetic mice.

Authors:  Nahla S El-Shenawy; Moamen S Refat; Fatima H Fakihi
Journal:  J Mater Sci Mater Med       Date:  2013-02-09       Impact factor: 3.896

3.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

4.  Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Fatemeh Ebrahimi; Amirhossein Sahebkar; Naheed Aryaeian; Naseh Pahlavani; Soudabeh Fallah; Nariman Moradi; Davoud Abbasi; Agha Fatemeh Hosseini
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-14       Impact factor: 3.168

5.  Validation of two generic patient-reported outcome measures in patients with type 2 diabetes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin
Journal:  Health Qual Life Outcomes       Date:  2007-07-31       Impact factor: 3.186

6.  The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease.

Authors:  Fariba Raygan; Zohreh Rezavandi; Fereshteh Bahmani; Vahidreza Ostadmohammadi; Mohammad Ali Mansournia; Maryam Tajabadi-Ebrahimi; Shokoofeh Borzabadi; Zatollah Asemi
Journal:  Diabetol Metab Syndr       Date:  2018-06-19       Impact factor: 3.320

7.  The Cholesterol Metabolite Cholest-5-en-3-One Alleviates Hyperglycemia and Hyperinsulinemia in Obese (db/db) Mice.

Authors:  Koji Nagao; Nao Inoue; Kunio Suzuki; Takeshi Shimizu; Teruyoshi Yanagita
Journal:  Metabolites       Date:  2021-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.